XBiotech Inc. (XBIT) › Operating Cash FlowXBiotech Inc. (XBIT) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2013: -$8.91M2014: -$11.70M2015: -$33.31M2016: -$46.02M2017: -$33.65M2018: -$16.54M2019: -$18.27M2020: -$65.15M2021: $69.44M2022: -$14.82M2023: -$18.73M2024: -$30.96M2025: -$39.92M-$39.92M2013Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$39.92M-28.9%2024-$30.96M-65.4%2023-$18.73M-26.3%2022-$14.82M-121.3%2021$69.44M+206.6%2020-$65.15M-256.6%2019-$18.27M-10.5%2018-$16.54M+50.9%2017-$33.65M+26.9%2016-$46.02M-38.1%2015-$33.31M-184.7%2014-$11.70M-31.3%2013-$8.91M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share